SXTP60 Degrees Pharmaceuticals Inc. Common Stock

1.130USD0.00%Mkt Cap: 3.97M $P/E:

60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers …

Key Statistics

Company
Market Cap3.97M $
Enterprise Value12.58M $
Revenue (TTM)1.21M $
Gross Profit223.78K $
Net Income (TTM)-7.37M $
Revenue/Share0.7620 USD
Last Price1.130 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-0.32
PEG
EV/EBITDA-1.48
EV/Revenue10.36
P/S3.27
P/B-0.43
EPS (TTM)-2.59
EPS (Forward)-3.58
52W Range
1.0201% of range8.620
52W High8.620 USD
52W Low1.020 USD
Profitability
Gross Margin22.26%
Oper. Margin-1092.41%
EBITDA Margin0.00%
Profit Margin-732.51%
ROE-212.67%
ROA-137.25%
Growth
Revenue Growth-32.50%
Earnings Growth
Cash Flow & Leverage
Operating CF-6.85M $
CapEx (TTM)218.08K $
FCF Margin-517.70%
FCF Yield-158.26%
Net Debt-871.43K $
Net Debt/EBITDA0.10
Balance Sheet
Debt/Equity0.04
Current Ratio2.33
Quick Ratio0.99
Book Value/Sh-2.6150 USD
Cash/Share0.2910 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:4
Split DateJan 20, 2026
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)3.700 USD
Upside (mean)+227.4%
Target Range3.700 USD3.700 USD
# Analysts1
Ownership
Shares Out.3.52M
Float2.09M
Insiders19.39%
Institutions17.11%
Short Interest
Short Ratio1.8d
Short % Float7.80%
Short % Out.7.73%
Shares Short205.64K
Short (prev mo.)112.38K
Technical
SMA 501.436 (-21.3%)
SMA 2002.408 (-53.1%)
Beta
S&P 52W Chg18.16%
Avg Vol (30d)67.37K
Avg Vol (10d)68.98K
Technical Indicators
RSI (14)36.6
MACD-0.0972
MACD Signal-0.1006
MACD Hist.+0.0034
BB Upper1.530 USD
BB Middle1.229 USD
BB Lower0.9271 USD
BB Width49.10%
ATR (14)0.1165 USD
Vol Ratio (20d)0.20x